Biogen Announces First Patient Treated With Higher Dose of SPINRAZA® (nusinersen) in Phase 2/3 DEVOTE StudyGlobeNewsWire • 04/02/20
So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be PrematureThe Motley Fool • 04/01/20
Biogen Has Entered The Coronavirus Drug Arena — But Is BIIB Stock A Buy?Investors Business Daily • 03/19/20
Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped TodayThe Motley Fool • 03/17/20
Sangamo's Partnership With Biogen Is Only One Big Pharma Partnership Based Off Of PipelineSeeking Alpha • 03/16/20
Biogen Foundation Commits $10 Million to Support COVID-19 Relief Efforts in the U.S. and Around the WorldGlobeNewsWire • 03/16/20